BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 70 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $69,000 | -43.0% | 41,032 | +13.6% | 0.00% | – |
| Q1 2019 | $121,000 | +572.2% | 36,134 | +472.9% | 0.00% | – |
| Q4 2018 | $18,000 | -63.3% | 6,307 | -5.4% | 0.00% | – |
| Q2 2018 | $49,000 | -2.0% | 6,668 | -14.0% | 0.00% | -100.0% |
| Q1 2018 | $50,000 | +25.0% | 7,750 | +60.7% | 0.00% | 0.0% |
| Q4 2017 | $40,000 | -72.4% | 4,823 | -61.6% | 0.00% | -66.7% |
| Q3 2017 | $145,000 | +195.9% | 12,576 | +199.3% | 0.01% | +200.0% |
| Q2 2017 | $49,000 | -49.5% | 4,202 | -47.0% | 0.00% | -50.0% |
| Q1 2017 | $97,000 | -12.6% | 7,934 | -3.4% | 0.00% | -42.9% |
| Q4 2016 | $111,000 | -67.5% | 8,214 | -52.3% | 0.01% | -69.6% |
| Q3 2016 | $342,000 | +824.3% | 17,210 | +498.8% | 0.02% | +1050.0% |
| Q2 2016 | $37,000 | +516.7% | 2,874 | +295.3% | 0.00% | – |
| Q1 2016 | $6,000 | -91.3% | 727 | -78.9% | 0.00% | -100.0% |
| Q4 2015 | $69,000 | – | 3,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|